This article details how Gilead allowed a toxic version of an HIV medication to stay on the market for over a decade just to prolong sales & protect patents. This drug Tenofovir or better know as half of Truvada. The company researched the toxicity of the medication & an acceptable replacement in 2004. Partway through the research,, the company shut the project down. In 2010 they restarted it & came up with the recently announced medication, Genvoya, or Truvada 2.0.
The reason for this was simple, profits. The original, overly toxic medicine was already approved & the patent on that would expire in 2018. Thus allowing generics to made. Gilead had already finished enough research a decade ago to know the new med was viable. All they had to was set back & wait. Then before the original med's patent expired, they'd introduce the new drug. Who'd want to make a generic version of a toxic medication?
It isn't like this is the 1st pharmaceutical company to pull this exact stunt. It won't be the last time they put their profits above the health of the people on them or needing them. These monsters justify anything & everything for profits. They're evil.
Read the article.
Cya...
No comments:
Post a Comment